The Chronicle of Philanthropy
PRESS CLIPPINGS

'Forbes': Charities Drive Drug Development

By putting up money for clinical trials, investing in biotechnology companies, and assembling networks of doctors and patients who want to participate in research, health charities are helping to drive the development of new treatments — and becoming important players in the pharmaceutical industry, writes...

To continue reading this Premium article, you must have a Chronicle account AND a subscription or online pass.

Subscriptions start at $42.50 for 12 issues; a 24-hour Web pass for under $10.

 

Subscribe | About The Chronicle | Contact us | Terms of use | Privacy policy | Help